Gayle Deflin

Insider Reports History

Location
Rancho Cucamonga, CA
Signature
/s/ Eva Wen, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gayle Deflin:

Company Role Class Num Shares Value Price $ Report Date Ownership
Amphastar Pharmaceuticals, Inc. Director Common Stock 10,914 $263,136 $24.11 02 Jun 2025 Direct
Amphastar Pharmaceuticals, Inc. Director Stock Option (right to buy) 11,402 02 Jun 2025 Direct

Insider Reports Filed by Gayle Deflin

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AMPH Amphastar Pharmaceuticals, Inc. 02 Jun 2025 2 $0 4 Director 04 Jun 2025, 19:45
AMPH Amphastar Pharmaceuticals, Inc. 03 Jun 2024 2 $0 4 Director 05 Jun 2024, 18:56
AMPH Amphastar Pharmaceuticals, Inc. 14 Nov 2023 1 -$230,838 4 Director 15 Nov 2023, 16:30
AMPH Amphastar Pharmaceuticals, Inc. 05 Jun 2023 2 $0 4 Director 07 Jun 2023, 17:18
AMPH Amphastar Pharmaceuticals, Inc. 18 May 2023 1 -$198,888 4 Director 19 May 2023, 18:30
AMPH Amphastar Pharmaceuticals, Inc. 15 May 2023 1 -$64,728 4 Director 17 May 2023, 16:05
AMPH Amphastar Pharmaceuticals, Inc. 10 Jun 2022 2 $0 4 Director 14 Jun 2022, 17:25
AMPH Amphastar Pharmaceuticals, Inc. 07 Jun 2021 2 $0 4 Director 08 Jun 2021, 20:51
AMPH Amphastar Pharmaceuticals, Inc. 07 Jun 2021 0 $0 3 Director 08 Jun 2021, 20:50